http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
COSMIC RAYS AND GAMMA-RAYS IN LARGE-SCALE STRUCTURE
INOUE SUSUMU,NAGASHIMA MASAHIRO,SUZUKI TAKERU K.,AOKI WAKO The Korean Astronomical Society 2004 Journal of The Korean Astronomical Society Vol.37 No.5
During the hierarchical formation of large scale structure in the universe, the progressive collapse and merging of dark matter should inevitably drive shocks into the gas, with nonthermal particle acceleration as a natural consequence. Two topics in this regard are discussed, emphasizing what important things nonthermal phenomena may tell us about the structure formation (SF) process itself. 1. Inverse Compton gamma-rays from large scale SF shocks and non-gravitational effects, and the implications for probing the warm-hot intergalactic medium. We utilize a semi-analytic approach based on Monte Carlo merger trees that treats both merger and accretion shocks self-consistently. 2. Production of $^6Li$ by cosmic rays from SF shocks in the early Galaxy, and the implications for probing Galaxy formation and uncertain physics on sub-Galactic scales. Our new observations of metal-poor halo stars with the Subaru High Dispersion Spectrograph are highlighted.
STANDARD SPECIFICATION FOR CONCRETE STRUCTURES, -2001 “MAINTENANCE”
Toyoaki Miyagawa,Hidenori Morikawa,Nobuaki Otsuki,Ayaho Miyamoto,Kazuo Eguchi,Hidenori Hamada,Atsushi Hattori,Tetsuo Harada,Susumu Inoue,Yuichi Kaneko,Yasushi Kamihigashi,Kenji Kawai,Masaru Kawamura,Y 대한토목학회 2003 대한토목학회 학술대회 Vol.2003 No.10
5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
( Jun Miyoshi ),( Katsuyoshi Matsuoka ),( Atsushi Yoshida ),( Makoto Naganuma ),( Tadakazu Hisamatsu ),( Tomoharu Yajima ),( Nagamu Inoue ),( Susumu Okamoto ),( Yasushi Iwao ),( Haruhiko Ogata ),( Fum 대한장연구학회 2018 Intestinal Research Vol.16 No.4
Ulcerative colitis (UC) is one of the major clinical phenotypes of inflammatory bowel diseases. Although 5-aminosalicylic acid (5-ASA) is widely used for UC and its efficacy and safety have been demonstrated, a few patients paradoxically develop a severe exacerbation of colitis by 5-ASA administration. It is crucial to know clinical features including endoscopic findings in this condition for making a correct diagnosis and a prompt decision to withdraw the medication. Here, we report case series with UC exacerbated by 5-ASA. Medical records of 8 UC patients experiencing an exacerbation of colitis after induction of 5-ASA that was improved by the withdrawal of 5-ASA but also re-aggravated by dose increase or re-administration of 5-ASA were reviewed. The patients were newly diagnosed with UC, started 5-ASA and developed an exacerbation in approximately 2 to 3 weeks. They did not appear to have systemic allergic reactions. Seven of the 8 patients had a high fever. Three of 5 patients who undertook total colonoscopy showed right-side-dominant colitis. These findings suggest clinical characteristics in this condition. Further assessment of clinical and endoscopic features in more cases is necessary for establishing diagnostic criteria and understanding underlying mechanisms in those cases where 5-ASA aggravates the colitis. (Intest Res 2018;16:635-640)